Skip to product information

Post-Covid Inflammatory Risk Index Testing

Post-Covid Inflammatory Risk Index Testing

Regular price $5,000.00
Regular price Sale price $5,000.00
Save Sold out
10 People are looking at this
View full details
Selected Variant Image
Post-Covid Inflammatory Risk Index Testing
Regular price $5,000.00
Regular price Sale price $5,000.00
Selected Variant Image
Post-Covid Inflammatory Risk Index Testing
Regular price $5,000.00
Regular price Sale price $5,000.00
  • Description

  • Why Us?

The data suggest a significant association between levels of inflammatory markers and COVID-19 severity. All markers, except procalcitonin. These markers demonstrated a significant correlation with disease severity. These results could enhance our understanding of COVID-19 pathogenesis and help predict and manage severe cases.

Recommended: Those recovered from COVID-19

Basic Health Assessment    
-    Health Questionnaire    
-    Body Mass Index    
-    Height
-    Pulse    
-    Weight     

Blood test
-    CBC
-    C-reactive protein
-    Serum Amyloid A (SAA)
-    Creatine kinase-myoglobin binding (CK-MB)
-    ESR
-    WBC 
-    IGF-1

 Medical report 
 Consultation by doctor

Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.

VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.

MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.

CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity